Impax Laboratories has been struggling lately with problems at its manufacturing facilities, with the latest involving a re-inspection by the FDA that turned up at least seven issues of concern at the company's Hayward, California plant, two of which were "repeat observations."
More FDA inspection problems plague Impax
Impax Laboratories has been struggling lately with problems at its manufacturing facilities, with the latest involving a re-inspection by the FDA that turned up at least seven issues of concern at the company's Hayward, California plant, two of which were "repeat observations."